These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4539210)

  • 1. An improved method for separation of the fourth component of complement and C4 inactivating substance.
    Shimada K; Mayumi M; Sekine T; Nishioka K
    Jpn J Exp Med; 1972 Oct; 42(5):423-34. PubMed ID: 4539210
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation of Cls with purified Clr.
    Sakai K; Stroud RM
    Immunochemistry; 1974 Apr; 11(4):191-6. PubMed ID: 4212387
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion of the fourth complement component studied by crossed immunoelectrophoresis.
    Sjöholm AG; Laurell AB
    Clin Exp Immunol; 1973 Aug; 14(4):515-29. PubMed ID: 4127020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
    Ruddy S; Hunsicker LG; Austen KF
    J Immunol; 1972 Mar; 108(3):657-64. PubMed ID: 4622188
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation of the 3d component of guinea pig cmplement (C3)].
    Takahashi S; Okada H; Nishioka K
    Arerugi; 1970 Dec; 19(12):859-67. PubMed ID: 5531032
    [No Abstract]   [Full Text] [Related]  

  • 6. A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.
    Assimeh SN; Bing DH; Painter RH
    J Immunol; 1974 Jul; 113(1):225-34. PubMed ID: 4857625
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of the first component of human complement by affinity chromatography on human globulin linked to sepharose.
    Bing DH
    J Immunol; 1971 Nov; 107(5):1243-9. PubMed ID: 4107360
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation and characterization of the monospecific antiserum directed to the ninth component of human complement (C9).
    Kawachi-Takahashi S; Tanaka K; Takahashi M
    Jpn J Exp Med; 1974 Jun; 44(3):283-90. PubMed ID: 4215913
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of C 1S , a subunit of the first component of complement from human plasma.
    Okamura K; Muramatu M; Fujii S
    Biochim Biophys Acta; 1973 Jan; 295(1):252-7. PubMed ID: 4734355
    [No Abstract]   [Full Text] [Related]  

  • 10. Fourth component of human complement: description of a three polypeptide chain structure.
    Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1974 Nov; 140(5):1324-35. PubMed ID: 4424566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 13. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 15. A new preparative method for isolation of human C3 with affinity chromatography.
    Molenaar JL; Müller M; Pondman KW
    J Immunol; 1973 Jun; 110(6):1570-4. PubMed ID: 4197305
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoelectrophoretic analysis of human seminal plasma fractions after fractionation by various methods.
    Li TS; Shulman S
    Int J Fertil; 1971; 16(2):87-100. PubMed ID: 5104783
    [No Abstract]   [Full Text] [Related]  

  • 17. [Components of human complement system. Testing and isolation of C4].
    Chikh VP; Kosiak AV; Shukun SA; Surovtsev VI
    Biokhimiia; 1990 Mar; 55(3):404-7. PubMed ID: 2354211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of the C4 inactivator from nurse shark serum.
    Fuller L; Iglesias E; Jensen JA
    Immunochemistry; 1974 Feb; 11(2):93-8. PubMed ID: 4207185
    [No Abstract]   [Full Text] [Related]  

  • 19. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 20. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
    Thompson RA
    Immunology; 1972 Jan; 22(1):147-58. PubMed ID: 4622449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.